These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33556204)

  • 1. Filter life and safety of heparin-grafted membrane for continuous renal replacement therapy - A randomized controlled trial.
    Wong ET; Ong V; Remani D; Wong WK; Haroon S; Lau T; Nyeo HQ; Mukhopadhyay A; Tan BH; Chua HR
    Semin Dial; 2021 Jul; 34(4):300-308. PubMed ID: 33556204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the AN69 ST100 versus oXiris
    Naorungroj T; Baldwin I; Eastwood G; Bellomo R
    Int J Artif Organs; 2023 Apr; 46(4):209-214. PubMed ID: 36895128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Clinical and Machine Data of Critically Ill Adult COVID Patients with Acute Kidney Injury Exposed to Enhanced Hemoadsorption during CRRT.
    Cama-Olivares A; Ortiz-Soriano V; Liu LJ; Carter S; Takeuchi T; Chen J; Tolwani AJ; Neyra JA
    Blood Purif; 2024; 53(6):476-485. PubMed ID: 38104535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous renal replacement therapies: anticoagulation in the critically ill at high risk of bleeding.
    Morabito S; Guzzo I; Solazzo A; Muzi L; Luciani R; Pierucci A
    J Nephrol; 2003; 16(4):566-71. PubMed ID: 14696760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Regional Citrate Anticoagulation vs Systemic Heparin Anticoagulation During Continuous Kidney Replacement Therapy on Dialysis Filter Life Span and Mortality Among Critically Ill Patients With Acute Kidney Injury: A Randomized Clinical Trial.
    Zarbock A; Küllmar M; Kindgen-Milles D; Wempe C; Gerss J; Brandenburger T; Dimski T; Tyczynski B; Jahn M; Mülling N; Mehrländer M; Rosenberger P; Marx G; Simon TP; Jaschinski U; Deetjen P; Putensen C; Schewe JC; Kluge S; Jarczak D; Slowinski T; Bodenstein M; Meybohm P; Wirtz S; Moerer O; Kortgen A; Simon P; Bagshaw SM; Kellum JA; Meersch M;
    JAMA; 2020 Oct; 324(16):1629-1639. PubMed ID: 33095849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracorporeal blood purification with Oxiris
    Abdelaty M; Mohamed A; Saad MO; Mitwally H; Alkadi MM; Hashim A; Al Malki H; Ali HS; Mohamed AS; Mustafa E; Alalawi A; Elshafei M; Othman M; Khatib M; Ibrahim AS
    Int J Artif Organs; 2023 Dec; 46(12):629-635. PubMed ID: 37926985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous renal replacement therapy without anticoagulation in critically ill patients at high risk of bleeding: A systematic review and meta-analysis.
    Zhang W; Bai M; Yu Y; Chen X; Zhao L; Chen X
    Semin Dial; 2021 May; 34(3):196-208. PubMed ID: 33400846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CRRT with oXiris filter on hemodynamic instability in surgical septic shock with AKI: A pilot randomized controlled trial.
    Feng J; Zhang S; Ai T; Wang L; Gao Y; Li W; Zhu M
    Int J Artif Organs; 2022 Oct; 45(10):801-808. PubMed ID: 35864718
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citrate versus heparin anticoagulation in continuous renal replacement therapy in small children.
    Raymakers-Janssen PAMA; Lilien M; van Kessel IA; Veldhoen ES; Wösten-van Asperen RM; van Gestel JPJ
    Pediatr Nephrol; 2017 Oct; 32(10):1971-1978. PubMed ID: 28578542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Proenkephalin A 119-159 for liberation from renal replacement therapy: an external, multicenter pilot study in critically ill patients with acute kidney injury.
    von Groote T; Albert F; Meersch M; Koch R; Gerss J; Arlt B; Sadjadi M; Porschen C; Pickkers P; Zarbock A;
    Crit Care; 2023 Jul; 27(1):276. PubMed ID: 37430375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epoprostenol (Prostacyclin Analog) as a Sole Anticoagulant in Continuous Renal Replacement Therapy for Critically Ill Children With Liver Disease: Single-Center Retrospective Study, 2010-2019.
    Deep A; Alexander EC; Khatri A; Kumari N; Sudheendhra K; Patel P; Joarder A; Elghuwael I
    Pediatr Crit Care Med; 2024 Jan; 25(1):15-23. PubMed ID: 38169336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: A meta-analysis of randomized controlled trials.
    Li R; Gao X; Zhou T; Li Y; Wang J; Zhang P
    Ther Apher Dial; 2022 Dec; 26(6):1086-1097. PubMed ID: 35385216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endotoxin and cytokine reducing properties of the oXiris membrane in patients with septic shock: A randomized crossover double-blind study.
    Broman ME; Hansson F; Vincent JL; Bodelsson M
    PLoS One; 2019; 14(8):e0220444. PubMed ID: 31369593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of citrate in cardiovascular system and clot circuit in critically ill patients requiring continuous renal replacement therapy.
    Trakarnvanich T; Sirivongrangson P; Trongtrakul K; Srisawat N
    J Artif Organs; 2023 Mar; 26(1):53-64. PubMed ID: 35412099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised trial of software algorithm driven regional citrate anticoagulation versus heparin in continuous renal replacement therapy: the Filter Life in Renal Replacement Therapy pilot trial.
    Brain MJ; Roodenburg OS; Adams N; McCracken P; Hockings L; Musgrave S; Butt W; Scheinkestel C
    Crit Care Resusc; 2014 Jun; 16(2):131-7. PubMed ID: 24888284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of citrate-based anticoagulation compared to heparin in patients with acute kidney injury requiring continuous renal replacement therapy: a randomized controlled trial.
    Stucker F; Ponte B; Tataw J; Martin PY; Wozniak H; Pugin J; Saudan P
    Crit Care; 2015 Mar; 19(1):91. PubMed ID: 25881975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of AN69 ST membrane on filter lifetime in continuous renal replacement therapy without anticoagulation in patients with high risk of bleeding].
    Yin Y; Zhao C; Hu Z; Wei S; Huo Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2015 May; 27(5):343-8. PubMed ID: 26003637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane pressures predict clotting of pediatric continuous renal replacement therapy circuits.
    Kakajiwala A; Jemielita T; Hughes JZ; Windt K; Denburg M; Goldstein SL; Laskin B
    Pediatr Nephrol; 2017 Jul; 32(7):1251-1261. PubMed ID: 28247082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hirudin versus heparin for anticoagulation in continuous renal replacement therapy.
    Vargas Hein O; von Heymann C; Lipps M; Ziemer S; Ronco C; Neumayer HH; Morgera S; Welte M; Kox WJ; Spies C
    Intensive Care Med; 2001 Apr; 27(4):673-9. PubMed ID: 11403068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States.
    Boldt D; Busse L; Chawla LS; Flannery AH; Khanna A; Neyra JA; Palmer P; Wilson J; Yessayan L
    Ren Fail; 2023; 45(2):2290932. PubMed ID: 38073554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.